Information Library
Results for: Faster product development - Clinical Services - Lifecycle Safety
In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions. Search our library today.
- Sort by:
- Recently Added
- Title
-
Quintiles Launches Innovative Center of Excellence in Dalian, China
Press Release — January 17, 2012 – Quintiles is opening a business process outsourcing (BPO) and project management center of excellence with a multilingual workforce and location ideally suited to serve the Japanese, Chinese and South Korean biopharmaceutical markets.
-
Quintiles Infosario Lifecycle Safety System Fact Sheet
Brochure — December 21, 2011
A comprehensive, cloud-based safety management system that increases customers agility and maximizes cost efficiency. A system designed to manage all safety activities across all programs, -
Quintiles Names Rick Sax New Head of Integrated Clinical Services
Press Release — May 23, 2011 – Quintiles announced the appointment of Frederic “Rick” Sax as Senior Vice President and Global Head of its Integrated Clinical Services division.rograms.
-
The Use of Large Simple Trials
Presentation — February 25, 2011
Quintiles presentation at CBI Late Phase Conference explores the design and application of Large Simple Trials as a cost effective approach to delivering high quality observational research data. -
Clinical – Smarter Trials, Accelerated Outcomes
Brochure — February 16, 2011
Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues. -
Managing Pharmacovigilance as a Business
White Paper — July 28, 2010
The three steps required to develop a strategic approach to global capacity management. -
Enabling Transformation
Case Study — September 30, 2009
Biovitrum found an ideal opportunity to transform itself into a fully integrated specialty pharmaceutical company from a biotech discovery and early clinical development company.
Page 1 of 1 (7 results)

